Cancer and access to travel insurance

That this House notes with concern that people who have cancer, or who have had cancer, who are declared fit to travel by NHS clinicians continue to face refusals and excessive premiums from travel insurers, creating a disconnect between clinical judgement and insurance practice; recognises that the process of seeking travel insurance is repeatedly described by people with cancer as confusing, exhausting and emotionally draining, adding an avoidable burden at an already stressful time; regrets that a lack of clear signposting leaves many people unaware that specialist providers may offer fairer cover, leading some to wrongly assume they are uninsurable, pay inflated premiums, or abandon travel altogether; believes that travel plays a significant role in the wellbeing and recovery of people with cancer, and that insurance barriers which discourage travel deny people positive experiences when they are most needed; further notes that with cancer cases projected to rise by 14 per cent over the next fifteen years, and people living longer with the disease, these barriers will only become more pressing unless action is taken; further believes that people who completed treatment years ago, or who are stable or clinically low risk, should not be required to declare historic cancer diagnoses indefinitely; also notes that several countries have adopted a Right to Be Forgotten model; and calls for a renewed debate on introducing a similar approach in the UK so that cancer survivors are no longer unfairly penalised for past illness.